Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 269

1.

A Multi-Level Analyses of Charges and Cost of Fall-Related Hospitalizations Among Older Adults: Individual, Hospital, and Geospatial Variation.

Towne SD, Smith ML, Li Y, Dowdy D, Ahn S, Lee S, Yoshikawa A, Jiang L.

J Aging Soc Policy. 2020 Mar 21:1-22. doi: 10.1080/08959420.2020.1740639. [Epub ahead of print]

PMID:
32202228
2.

Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective.

Nalugwa T, Shete PB, Nantale M, Farr K, Ojok C, Ochom E, Mugabe F, Joloba M, Dowdy DW, Moore DAJ, Davis JL, Cattamanchi A, Katamba A.

BMC Health Serv Res. 2020 Mar 4;20(1):162. doi: 10.1186/s12913-020-4997-x.

3.

Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics.

Tucker A, Tembo T, Tampi RP, Mutale J, Mukumba-Mwenechanya M, Sharma A, Dowdy DW, Moore CB, Geng E, Holmes CB, Sikazwe I, Sohn H.

J Int AIDS Soc. 2020 Feb;23(2):e25431. doi: 10.1002/jia2.25431.

4.

Patient-incurred cost of inpatient treatment for Tuberculosis in rural Malawi.

Shin H, Ngwira LG, Tucker A, Chaisson RE, Corbett EL, Dowdy DW.

Trop Med Int Health. 2020 Feb 8. doi: 10.1111/tmi.13381. [Epub ahead of print]

PMID:
32034984
5.

Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.

Hong H, Dowdy DW, Dooley KE, Francis HW, Budhathoki C, Han HR, Farley JE.

Int J Tuberc Lung Dis. 2020 Jan 1;24(1):65-72. doi: 10.5588/ijtld.19.0062.

PMID:
32005308
6.

Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial.

Fox GJ, Nguyen CB, Nguyen TA, Tran PT, Marais BJ, Graham SM, Nguyen BH, Velen K, Dowdy DW, Mason P, Britton WJ, Behr MA, Benedetti A, Menzies D, Nguyen VN, Marks GB.

BMJ Open. 2020 Jan 2;10(1):e033945. doi: 10.1136/bmjopen-2019-033945.

7.

Clinical impact of rapid drug susceptibility testing to accompany fluoroquinolone-containing universal tuberculosis regimens: a Markov model.

Kendall EA, Malhotra S, Cook-Scalise S, Dowdy DW, Denkinger CM.

Clin Infect Dis. 2019 Dec 9. pii: ciz1179. doi: 10.1093/cid/ciz1179. [Epub ahead of print]

PMID:
31813958
8.

Overcoming limitations of tuberculosis information systems: researcher and clinician perspectives.

van der Heijden YF, Hughes J, Dowdy DW, Streicher E, Chihota V, Jacobson KR, Warren R, Theron G.

Public Health Action. 2019 Sep 21;9(3):120-127. doi: 10.5588/pha.19.0014.

9.

Projecting the impact of variable MDR-TB transmission efficiency on long-term epidemic trends in South Africa and Vietnam.

Salvatore PP, Kendall EA, Seabrook D, Brown J, Durham GH, Dowdy DW.

Sci Rep. 2019 Dec 2;9(1):18099. doi: 10.1038/s41598-019-54561-9.

10.

Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up.

Farr K, Nalugwa T, Ojok C, Nantale M, Nabwire S, Oyuku D, Shete PB, Han AH, Fielding K, Joloba M, Mugabe F, Dowdy DW, Moore D, Davis JL, Katamba A, Cattamanchi A.

J Clin Tuberc Other Mycobact Dis. 2019 Apr 12;15:100099. doi: 10.1016/j.jctube.2019.100099. eCollection 2019 May.

11.

Tuberculosis patients with higher levels of poverty face equal or greater costs of illness.

Erlinger S, Stracker N, Hanrahan C, Nonyane S, Mmolawa L, Tampi R, Tucker A, West N, Lebina L, Martinson NA, Dowdy D.

Int J Tuberc Lung Dis. 2019 Nov 1;23(11):1205-1212. doi: 10.5588/ijtld.18.0814.

PMID:
31718757
12.

Implementation of Xpert® MTB/RIF: real challenges, real promise.

Dowdy DW.

Int J Tuberc Lung Dis. 2019 Oct 1;23(10):1123. doi: 10.5588/ijtld.19.0120. No abstract available.

PMID:
31627779
13.

Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California.

Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay GR, Barry P, Readhead A, Flood J, Kahn JG, Shete PB.

Am J Respir Crit Care Med. 2020 Feb 1;201(3):356-365. doi: 10.1164/rccm.201907-1289OC.

PMID:
31626560
14.

Clinical Consequences of Using an Indeterminate Range for Early Infant Diagnosis of HIV: A Decision Model.

Salvatore P, Johnson K, Vojnov L, Doherty M, Dowdy D.

J Acquir Immune Defic Syndr. 2019 Nov 1;82(3):287-296. doi: 10.1097/QAI.0000000000002155.

PMID:
31609928
15.

Ending the Human Immunodeficiency Virus Epidemic: Towards an Evidence-Based Approach.

Fojo AT, Dowdy DW.

Clin Infect Dis. 2019 Nov 27;69(12):2199-2200. doi: 10.1093/cid/ciz1018. No abstract available.

PMID:
31609445
16.

Guidance for Studies Evaluating the Accuracy of Tuberculosis Triage Tests.

Nathavitharana RR, Yoon C, Macpherson P, Dowdy DW, Cattamanchi A, Somoskovi A, Broger T, Ottenhoff THM, Arinaminpathy N, Lonnroth K, Reither K, Cobelens F, Gilpin C, Denkinger CM, Schumacher SG.

J Infect Dis. 2019 Oct 8;220(Supplement_3):S116-S125. doi: 10.1093/infdis/jiz243.

PMID:
31593600
17.

Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV.

Kendall EA, Durovni B, Martinson NA, Cavalacante S, Masonoke K, Saraceni V, Lebina L, Efron A, Cohn S, Chon S, Chaisson RE, Dowdy DW, Golub JE; THRio and TEKO teams.

AIDS. 2020 Jan 1;34(1):63-71. doi: 10.1097/QAD.0000000000002380.

PMID:
31567163
18.

Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations.

Kendall EA, Malhotra S, Cook-Scalise S, Denkinger CM, Dowdy DW.

BMC Infect Dis. 2019 Sep 9;19(1):794. doi: 10.1186/s12879-019-4429-x.

19.

Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model.

Sohn H, Kasaie P, Kendall E, Gomez GB, Vassall A, Pai M, Dowdy D.

BMC Med. 2019 Aug 6;17(1):155. doi: 10.1186/s12916-019-1384-8.

20.

Home-based tuberculosis contact investigation in Uganda: a household randomised trial.

Davis JL, Turimumahoro P, Meyer AJ, Ayakaka I, Ochom E, Ggita J, Mark D, Babirye D, Okello DA, Mugabe F, Fair E, Vittinghoff E, Armstrong-Hough M, Dowdy D, Cattamanchi A, Haberer JE, Katamba A.

ERJ Open Res. 2019 Jul 29;5(3). pii: 00112-2019. doi: 10.1183/23120541.00112-2019. eCollection 2019 Jul.

21.

Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration.

Salazar-Austin N, Dowdy DW, Chaisson RE, Golub JE.

Am J Epidemiol. 2019 Dec 31;188(12):2078-2085. doi: 10.1093/aje/kwz172.

PMID:
31364692
22.

Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses.

Kendall EA, Kamoga C, Kitonsa PJ, Nalutaaya A, Salvatore PP, Robsky K, Nakasolya O, Mukiibi J, Isooba D, Cattamanchi A, Kato-Maeda M, Katamba A, Dowdy DW.

PLoS One. 2019 Jul 24;14(7):e0220251. doi: 10.1371/journal.pone.0220251. eCollection 2019.

23.

Risk factors for catastrophic costs associated with tuberculosis in rural South Africa.

Stracker N, Hanrahan C, Mmolawa L, Nonyane B, Tampi R, Tucker A, West N, Lebina L, Martinson N, Dowdy D.

Int J Tuberc Lung Dis. 2019 Jun 1;23(6):756-763. doi: 10.5588/ijtld.18.0519.

24.

A Systematic Review to Evaluate the Association between Clean Cooking Technologies and Time Use in Low- and Middle-Income Countries.

Simkovich SM, Williams KN, Pollard S, Dowdy D, Sinharoy S, Clasen TF, Puzzolo E, Checkley W.

Int J Environ Res Public Health. 2019 Jun 27;16(13). pii: E2277. doi: 10.3390/ijerph16132277.

25.

Impact and Effectiveness of State-Level Tuberculosis Interventions in California, Florida, New York, and Texas: A Model-Based Analysis.

Shrestha S, Cherng S, Hill AN, Reynolds S, Flood J, Barry PM, Readhead A, Oxtoby M, Lauzardo M, Privett T, Marks SM, Dowdy DW.

Am J Epidemiol. 2019 Sep 1;188(9):1733-1741. doi: 10.1093/aje/kwz147.

PMID:
31251797
26.

Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries.

Campbell JR, Dowdy D, Schwartzman K.

PLoS Med. 2019 Jun 6;16(6):e1002824. doi: 10.1371/journal.pmed.1002824. eCollection 2019 Jun. Review.

27.

Reply to Chen, Song, and Liu.

Hong H, Dowdy DW.

Clin Infect Dis. 2020 Jan 16;70(3):547-548. doi: 10.1093/cid/ciz447. No abstract available.

PMID:
31139833
28.

The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection.

Jo Y, Dowdy DW.

Lancet Infect Dis. 2019 Jul;19(7):675-676. doi: 10.1016/S1473-3099(19)30054-4. Epub 2019 May 23. No abstract available.

29.

Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation.

Pooran A, Theron G, Zijenah L, Chanda D, Clowes P, Mwenge L, Mutenherwa F, Lecesse P, Metcalfe J, Sohn H, Hoelscher M, Pym A, Peter J, Dowdy D, Dheda K.

Lancet Glob Health. 2019 Jun;7(6):e798-e807. doi: 10.1016/S2214-109X(19)30164-0. Erratum in: Lancet Glob Health. 2019 Sep;7(9):e1179.

30.

What will it take to eliminate drug-resistant tuberculosis?

Kendall EA, Sahu S, Pai M, Fox GJ, Varaine F, Cox H, Cegielski JP, Mabote L, Vassall A, Dowdy DW.

Int J Tuberc Lung Dis. 2019 May 1;23(5):535-546. doi: 10.5588/ijtld.18.0217.

31.

Contact tracing versus facility-based screening for active TB case finding in rural South Africa: A pragmatic cluster-randomized trial (Kharitode TB).

Hanrahan CF, Nonyane BAS, Mmolawa L, West NS, Siwelana T, Lebina L, Martinson N, Dowdy DW.

PLoS Med. 2019 Apr 30;16(4):e1002796. doi: 10.1371/journal.pmed.1002796. eCollection 2019 Apr.

32.

Differentiated Care Preferences of Stable Patients on Antiretroviral Therapy in Zambia: A Discrete Choice Experiment.

Eshun-Wilson I, Mukumbwa-Mwenechanya M, Kim HY, Zannolini A, Mwamba CP, Dowdy D, Kalunkumya E, Lumpa M, Beres LK, Roy M, Sharma A, Topp SM, Glidden DV, Padian N, Ehrenkranz P, Sikazwe I, Holmes CB, Bolton-Moore C, Geng EH.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):540-546. doi: 10.1097/QAI.0000000000002070.

33.

Operational characteristics of antiretroviral therapy clinics in Zambia: a time and motion analysis.

Tampi RP, Tembo T, Mukumba-Mwenechanya M, Sharma A, Dowdy DW, Holmes CB, Bolton-Moore C, Sikazwe I, Tucker A, Sohn H.

BMC Health Serv Res. 2019 Apr 24;19(1):244. doi: 10.1186/s12913-019-4096-z.

34.

Aminoglycoside-induced Hearing Loss Among Patients Being Treated for Drug-resistant Tuberculosis in South Africa: A Prediction Model.

Hong H, Dowdy DW, Dooley KE, Francis HW, Budhathoki C, Han HR, Farley JE.

Clin Infect Dis. 2020 Feb 14;70(5):917-924. doi: 10.1093/cid/ciz289.

PMID:
30963176
35.

From Epidemiologic Knowledge to Improved Health: A Vision for Translational Epidemiology.

Windle M, Lee HD, Cherng ST, Lesko CR, Hanrahan C, Jackson JW, McAdams-DeMarco M, Ehrhardt S, Baral SD, D'Souza G, Dowdy DW.

Am J Epidemiol. 2019 Dec 31;188(12):2049-2060. doi: 10.1093/aje/kwz085.

PMID:
30927354
36.

Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study.

Kasaie P, Schumacher CM, Jennings JM, Berry SA, Tuddenham SA, Shah MS, Rosenberg ES, Hoover KW, Gift TL, Chesson H, German D, Dowdy DW.

BMJ Open. 2019 Mar 4;9(3):e023453. doi: 10.1136/bmjopen-2018-023453.

37.

Screening for tuberculosis: time to move beyond symptoms.

Yoon C, Dowdy DW, Esmail H, MacPherson P, Schumacher SG.

Lancet Respir Med. 2019 Mar;7(3):202-204. doi: 10.1016/S2213-2600(19)30039-6. No abstract available.

38.

Xpert at 8 years: where are we now, and what should we do next?

Dowdy DW.

Int J Tuberc Lung Dis. 2019 Jan 1;23(1):3-4. doi: 10.5588/ijtld.18.0717. No abstract available.

PMID:
30674373
39.

Siyaphambili protocol: An evaluation of randomized, nurse-led adaptive HIV treatment interventions for cisgender female sex workers living with HIV in Durban, South Africa.

Comins CA, Schwartz SR, Phetlhu DR, Guddera V, Young K, Farley JE, West N, Parmley L, Geng E, Beyrer C, Dowdy D, Mishra S, Hausler H, Baral S.

Res Nurs Health. 2019 Apr;42(2):107-118. doi: 10.1002/nur.21928. Epub 2019 Jan 15.

PMID:
30644999
40.

Cost-effectiveness of universal isoniazid preventive therapy among HIV-infected pregnant women in South Africa.

Kim HY, Hanrahan CF, Martinson N, Golub JE, Dowdy DW.

Int J Tuberc Lung Dis. 2018 Dec 1;22(12):1435-1442. doi: 10.5588/ijtld.18.0370.

41.

Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings.

Cudahy PGT, Andrews JR, Bilinski A, Dowdy DW, Mathema B, Menzies NA, Salomon JA, Shrestha S, Cohen T.

Lancet Infect Dis. 2019 Mar;19(3):e89-e95. doi: 10.1016/S1473-3099(18)30443-2. Epub 2018 Dec 13. Review.

42.

Attitudes, Beliefs, and Cost-Related Medication Nonadherence Among Adults Aged 65 or Older With Chronic Diseases.

Lee S, Jiang L, Dowdy D, Hong YA, Ory MG.

Prev Chronic Dis. 2018 Dec 6;15:E148. doi: 10.5888/pcd15.180190.

43.

Maternal Motivation to Take Preventive Therapy in Antepartum and Postpartum Among HIV-Positive Pregnant Women in South Africa: A Choice Experiment.

Kim HY, Dowdy DW, Martinson NA, Kerrigan D, Tudor C, Golub J, Bridges JFP, Hanrahan CF.

AIDS Behav. 2019 Jul;23(7):1689-1697. doi: 10.1007/s10461-018-2324-x.

PMID:
30415430
44.

Simple Inclusion of Complex Diagnostic Algorithms in Infectious Disease Models for Economic Evaluation.

Dodd PJ, Pennington JJ, Bronner Murrison L, Dowdy DW.

Med Decis Making. 2018 Nov;38(8):930-941. doi: 10.1177/0272989X18807438.

45.

Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain.

Kasaie P, Radford M, Kapoor S, Jung Y, Hernandez Novoa B, Dowdy D, Shah M.

PLoS One. 2018 Nov 5;13(11):e0206755. doi: 10.1371/journal.pone.0206755. eCollection 2018.

46.

Tuberculosis Incidence Among Populations at High Risk in California, Florida, New York, and Texas, 2011-2015.

Cherng ST, Shrestha S, Reynolds S, Hill AN, Marks SM, Kelly J, Dowdy DW.

Am J Public Health. 2018 Nov;108(S4):S311-S314. doi: 10.2105/AJPH.2018.304503.

47.

The Importance of Heterogeneity to the Epidemiology of Tuberculosis.

Trauer JM, Dodd PJ, Gomes MGM, Gomez GB, Houben RMGJ, McBryde ES, Melsew YA, Menzies NA, Arinaminpathy N, Shrestha S, Dowdy DW.

Clin Infect Dis. 2019 Jun 18;69(1):159-166. doi: 10.1093/cid/ciy938.

48.

Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting.

Kendall EA, Azman AS, Maartens G, Boulle A, Wilkinson RJ, Dowdy DW, Rangaka MX.

AIDS. 2019 Mar 1;33(3):525-536. doi: 10.1097/QAD.0000000000002053.

49.

'Something so hard': a mixed-methods study of home sputum collection for tuberculosis contact investigation in Uganda.

Armstrong-Hough M, Ggita J, Turimumahoro P, Meyer AJ, Ochom E, Dowdy D, Cattamanchi A, Katamba A, Davis JL.

Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1152-1159. doi: 10.5588/ijtld.18.0129.

50.

Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.

Yoon C, Semitala FC, Asege L, Katende J, Mwebe S, Andama AO, Atuhumuza E, Nakaye M, Armstrong DT, Dowdy DW, McCulloch CE, Kamya M, Cattamanchi A.

Am J Respir Crit Care Med. 2019 Mar 1;199(5):643-650. doi: 10.1164/rccm.201803-0490OC.

Supplemental Content

Support Center